309 related articles for article (PubMed ID: 19601801)
21. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease.
Akhmedov A; Sawamura T; Chen CH; Kraler S; Vdovenko D; Lüscher TF
Eur Heart J; 2021 May; 42(18):1797-1807. PubMed ID: 36282110
[TBL] [Abstract][Full Text] [Related]
22. LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation.
Pothineni NVK; Karathanasis SK; Ding Z; Arulandu A; Varughese KI; Mehta JL
J Am Coll Cardiol; 2017 Jun; 69(22):2759-2768. PubMed ID: 28571642
[TBL] [Abstract][Full Text] [Related]
23. Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).
Renie G; Maingrette F; Li L
Curr Diabetes Rev; 2007 May; 3(2):103-10. PubMed ID: 18220661
[TBL] [Abstract][Full Text] [Related]
24. LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.
Chistiakov DA; Orekhov AN; Bobryshev YV
Cell Physiol Biochem; 2016; 38(5):1851-9. PubMed ID: 27160316
[TBL] [Abstract][Full Text] [Related]
25. Chaperonin-containing TCP-1 complex directly binds to the cytoplasmic domain of the LOX-1 receptor.
Bakthavatsalam D; Soung RH; Tweardy DJ; Chiu W; Dixon RA; Woodside DG
FEBS Lett; 2014 Jun; 588(13):2133-40. PubMed ID: 24846140
[TBL] [Abstract][Full Text] [Related]
26. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
Morawietz H
Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
[TBL] [Abstract][Full Text] [Related]
27. Myeloperoxidase-Oxidized LDL Activates Human Aortic Endothelial Cells through the LOX-1 Scavenger Receptor.
El-Hajjar L; Hindieh J; Andraos R; El-Sabban M; Daher J
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269979
[TBL] [Abstract][Full Text] [Related]
28. LOX-1 and obesity.
Yan M; Mehta JL; Hu C
Cardiovasc Drugs Ther; 2011 Oct; 25(5):469-76. PubMed ID: 21881850
[TBL] [Abstract][Full Text] [Related]
29. Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1.
Takemura Y; Okamoto M; Hasegawa M; Hatanaka K; Kubota S
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1094-1101. PubMed ID: 30871430
[TBL] [Abstract][Full Text] [Related]
30. Oxidized LDL, LOX-1 and atherosclerosis.
Mitra S; Goyal T; Mehta JL
Cardiovasc Drugs Ther; 2011 Oct; 25(5):419-29. PubMed ID: 21947818
[TBL] [Abstract][Full Text] [Related]
31. ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production.
Mattaliano MD; Wooters J; Shih HH; Paulsen JE
Am J Physiol Cell Physiol; 2010 May; 298(5):C1180-7. PubMed ID: 20181930
[TBL] [Abstract][Full Text] [Related]
32. Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.
Sun Y; Chen X
Fundam Clin Pharmacol; 2011 Oct; 25(5):572-9. PubMed ID: 21077940
[TBL] [Abstract][Full Text] [Related]
33. Association of angiotensin II receptor 1 and lectin-like oxidized low-density lipoprotein receptor-1 mediates the cardiac hypertrophy induced by oxidized low-density lipoprotein.
Zhao Y; Li Y; Ning X; Chen K; Zhang S
Biochem Biophys Res Commun; 2017 Aug; 490(1):55-61. PubMed ID: 28595908
[TBL] [Abstract][Full Text] [Related]
34. Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Inflammation and Pathogen-Associated Interactions.
Truthe S; Klassert TE; Schmelz S; Jonigk D; Blankenfeldt W; Slevogt H
J Innate Immun; 2024; 16(1):105-132. PubMed ID: 38232720
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor.
Vohra RS; Murphy JE; Walker JH; Ponnambalam S; Homer-Vanniasinkam S
Trends Cardiovasc Med; 2006 Feb; 16(2):60-4. PubMed ID: 16473764
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells.
Pirillo A; Reduzzi A; Ferri N; Kuhn H; Corsini A; Catapano AL
Atherosclerosis; 2011 Feb; 214(2):331-7. PubMed ID: 21130457
[TBL] [Abstract][Full Text] [Related]
37. LOX-1: a male hormone-regulated scavenger receptor for atherosclerosis.
Gao S; Geng YJ
Vascul Pharmacol; 2013; 59(5-6):138-43. PubMed ID: 24157503
[TBL] [Abstract][Full Text] [Related]
38. Granulosa cell subtypes respond by autophagy or cell death to oxLDL-dependent activation of the oxidized lipoprotein receptor 1 and toll-like 4 receptor.
Serke H; Vilser C; Nowicki M; Hmeidan FA; Blumenauer V; Hummitzsch K; Lösche A; Spanel-Borowski K
Autophagy; 2009 Oct; 5(7):991-1003. PubMed ID: 19730000
[TBL] [Abstract][Full Text] [Related]
39. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo.
Akhmedov A; Rozenberg I; Paneni F; Camici GG; Shi Y; Doerries C; Sledzinska A; Mocharla P; Breitenstein A; Lohmann C; Stein S; von Lukowicz T; Kurrer MO; Borén J; Becher B; Tanner FC; Landmesser U; Matter CM; Lüscher TF
Eur Heart J; 2014 Oct; 35(40):2839-48. PubMed ID: 24419805
[TBL] [Abstract][Full Text] [Related]
40. Chlamydia pneumoniae infection enhances lectin-like oxidized low-density lipoprotein receptor (LOX-1) expression on human endothelial cells.
Yoshida T; Koide N; Mori I; Ito H; Yokochi T
FEMS Microbiol Lett; 2006 Jul; 260(1):17-22. PubMed ID: 16790013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
